{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:27:21Z","timestamp":1761128841504},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jbspin.2010.04.014","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T04:47:04Z","timestamp":1276145224000},"page":"414-417","source":"Crossref","is-referenced-by-count":8,"title":["TNF\u03b1 antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis"],"prefix":"10.1016","volume":"77","author":[{"given":"Marion","family":"Couderc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Payet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Henquell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Dubost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.04.014_bib1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/ard.2005.047514","article-title":"Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study","volume":"65","author":"Askling","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.jbspin.2010.04.014_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jbspin.2007.05.001","article-title":"Pathophysiological links between rheumatoid arthritis and the Epstein Barr virus: an update","volume":"74","author":"Toussirot","year":"2007","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.jbspin.2010.04.014_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune disease","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib5","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2010.04.014_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002018-199920060-00002","article-title":"Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?","volume":"20","author":"Georgescu","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.jbspin.2010.04.014_bib7","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloun","year":"1996","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib8","first-page":"2249","article-title":"Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE","volume":"26","author":"Kono","year":"1999","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2141.2002.03619.x","article-title":"Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature","volume":"118","author":"Baird","year":"2002","journal-title":"Br. J.\u00a0Haematol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0025-6196(11)63231-X","article-title":"Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate","volume":"76","author":"Tournadre","year":"2001","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.jbspin.2010.04.014_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2005.10.004","article-title":"for the RATIO Study Group The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TNFalpha therapy","volume":"72","author":"Tubach","year":"2005","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.jbspin.2010.04.014_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/s10165-008-0053-0","article-title":"Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis","volume":"18","author":"Komatsuda","year":"2008","journal-title":"Mod Rheumatol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-007-0467-6","article-title":"Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment","volume":"18","author":"Park","year":"2008","journal-title":"Rheumatol Int."},{"issue":"5 Suppl. 1","key":"10.1016\/j.jbspin.2010.04.014_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semarthrit.2005.01.008","article-title":"What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?","volume":"34","author":"Balandraud","year":"2005","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib15","unstructured":"Recommandations SFR et CRI sur l\u2019utilisation des anti-TNF\u03b1 dans la PR et la Spondylarthrite ankylosante. http:\/\/www.cri-net.com\/recherche\/fichesPratiques\/recommandations.asp."},{"key":"10.1016\/j.jbspin.2010.04.014_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/rheumatology\/keh696","article-title":"Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis","volume":"9","author":"Torre-Cisneros","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2010.04.014_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.22783","article-title":"Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis","volume":"5","author":"Balandraud","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn's disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.jbspin.2010.04.014_bib19","first-page":"18","article-title":"Potential role of Epstein-Barr virus in Sj\u00f6gren's syndrome and rheumatoid arthritis","volume":"32","author":"Fox","year":"1992","journal-title":"J Rheumatol Suppl."},{"key":"10.1016\/j.jbspin.2010.04.014_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/infdis\/164.1.22","article-title":"Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sj\u00f6gren's syndrome and with rheumatoid arthritis","volume":"164","author":"Inoue","year":"1991","journal-title":"J Infect Dis."},{"key":"10.1016\/j.jbspin.2010.04.014_bib21","first-page":"1442","article-title":"Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera","volume":"17","author":"Kouri","year":"1990","journal-title":"J Rheumatol."},{"key":"10.1016\/j.jbspin.2010.04.014_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","article-title":"Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis","volume":"67","author":"Alspaugh","year":"1981","journal-title":"J Clin Invest."},{"key":"10.1016\/j.jbspin.2010.04.014_bib23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1084\/jem.147.4.1018","article-title":"Lymphocytes transformed by Epstein-Barr virus Induction of nuclear antigen reactive with antibody in rheumatoid arthritis","volume":"147","author":"Alspaugh","year":"1978","journal-title":"J Exp Med."},{"key":"10.1016\/j.jbspin.2010.04.014_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","article-title":"Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study","volume":"18","author":"Baecklund","year":"1998","journal-title":"BMJ."},{"key":"10.1016\/j.jbspin.2010.04.014_bib25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"19","author":"Bongartz","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.jbspin.2010.04.014_bib26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/ard.2008.094904","article-title":"Etanercept therapy in rheumatoid arthritis and the risk of malignancies. A systematic review and individual patient data meta-analysis of randomised controlled trials","volume":"68","author":"Bongartz","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.jbspin.2010.04.014_bib27","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.22056","article-title":"Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis","volume":"54","author":"Setoguchi","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib28","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib29","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.04.014_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2007.085852","article-title":"Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register","volume":"68","author":"Askling","year":"2009","journal-title":"Ann Rheum Dis."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10001338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10001338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:37:59Z","timestamp":1559162279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10001338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1297319X10001338"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.04.014","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}